Hydrogen Sulfide and Platelets: A Possible Role in Thrombosis
1National Heart and Lung Institute, Imperial College London, London, SW7 2AZ, UK, m.emerson@imperial.ac.uk.
Handbook of Experimental Pharmacology
|July 12, 2015
Summary
Hydrogen sulfide (H2S) is emerging as a key regulator of platelet function, inhibiting aggregation and exerting anti-thrombotic effects. Further research is needed to understand its role in cardiovascular diseases like myocardial infarction and stroke.
Area of Science:
- Biochemistry
- Hematology
- Physiology
Background:
- Platelets are crucial for hemostasis and thrombosis, activated by various stimuli.
- Nitric oxide is a known inhibitory gasotransmitter affecting platelet function.
- Emerging evidence suggests endogenous hydrogen sulfide (H2S) generation and function within platelets.
Purpose of the Study:
- To investigate the role of hydrogen sulfide (H2S) in regulating platelet activation and function.
- To explore the mechanisms underlying H2S effects on platelets.
- To assess the potential of H2S as a therapeutic target in thrombotic disorders.
Main Methods:
- Utilized slow-release H2S compounds to study platelet aggregation in vitro.
- Evaluated anti-thrombotic effects of H2S in vivo.
- Investigated the interaction between H2S and other gasotransmitters in platelet signaling.
Main Results:
- Exogenous H2S exposure inhibited platelet aggregation.
- H2S demonstrated significant anti-thrombotic effects in vivo.
- The precise mechanisms and interactions with other gasotransmitters require further elucidation.
Conclusions:
- Hydrogen sulfide (H2S) emerges as a novel and important regulator of platelet activation.
- H2S exhibits anti-thrombotic properties, suggesting therapeutic potential.
- Further studies are essential to fully understand H2S's role in platelet physiology and cardiovascular pathology.
Related Concept Videos
01:22Formation of the Platelet Plug
10.8K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
10.8K
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
2.4K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
2.4K
01:05Introduction to Hemostasis
17.4K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
17.4K
01:18Structure and Function of Platelets
5.5K
The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
5.5K
01:16Clot Retraction and Fibrinolysis
10.3K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
10.3K
01:20Extrinsic and Intrinsic Pathways of Hemostasis
15.6K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
15.6K